About shionogi & co. ltd. - SGIOF
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
SGIOF At a Glance
Shionogi & Co., Ltd.
3-1-8 Dosho-machi
Osaka, Osaka 541-0045
| Phone | 81-6-6202-2161 | Revenue | 3.32B | |
| Industry | Pharmaceuticals: Major | Net Income | 1.36B | |
| Sector | Health Technology | 2026 Sales Growth | 15.342% | |
| Fiscal Year-end | 03 / 2027 | Employees | 6,223 | |
| View SEC Filings |
SGIOF Valuation
| P/E Current | 11.75 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 13.628 |
| Price to Sales Ratio | 5.597 |
| Price to Book Ratio | 1.752 |
| Price to Cash Flow Ratio | 13.09 |
| Enterprise Value to EBITDA | 14.718 |
| Enterprise Value to Sales | 5.548 |
| Total Debt to Enterprise Value | 0.234 |
SGIOF Efficiency
| Revenue/Employee | 532,842.818 |
| Income Per Employee | 218,777.395 |
| Receivables Turnover | 3.302 |
| Total Asset Turnover | 0.251 |
SGIOF Liquidity
| Current Ratio | 1.584 |
| Quick Ratio | 1.463 |
| Cash Ratio | 0.86 |
SGIOF Profitability
| Gross Margin | 80.96 |
| Operating Margin | 32.297 |
| Pretax Margin | 48.273 |
| Net Margin | 41.059 |
| Return on Assets | 10.289 |
| Return on Equity | 13.822 |
| Return on Total Capital | 9.14 |
| Return on Invested Capital | 13.654 |
SGIOF Capital Structure
| Total Debt to Total Equity | 40.612 |
| Total Debt to Total Capital | 28.882 |
| Total Debt to Total Assets | 26.559 |
| Long-Term Debt to Equity | 1.121 |
| Long-Term Debt to Total Capital | 0.797 |